XML 59 R35.htm IDEA: XBRL DOCUMENT v3.3.0.814
Employee Stock Award, Option and Benefit Plans (Tables)
12 Months Ended
Oct. 03, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of deferred compensation plans' investments and liabilities
These investments and the liability to the employees were as follows (in thousands):
 
Fiscal Year-end
 
2015
 
2014
Cash surrender value of life insurance contracts
$
12,780

 
$
12,999

Fair value of mutual funds
13,891

 
15,000

Total assets
$
26,671

 
$
27,999

 
 
 
 
Total assets, included in:
 

 
 

Prepaid expenses and other assets
$
1,540

 
$
1,515

Other assets
25,131

 
26,484

Total assets
$
26,671

 
$
27,999


 
Fiscal Year-end
 
2015
 
2014
Total deferred compensation liability, included in:
 
 
 
Other current liabilities
$
1,540

 
$
1,515

Other long-term liabilities
26,691

 
27,858

Total deferred compensation liability
$
28,231

 
$
29,373

Schedule of weighted-average assumptions used to estimate fair value of stock options granted and shares purchased
The fair values of shares purchased under the employee stock purchase plan for fiscal 2015, 2014 and 2013 were estimated using the following weighted-average assumptions:
 
 
Employee Stock
Purchase Plans
 
 
Fiscal
 
 
2015
 
2014
 
2013
Expected life in years
 
0.5

 
0.5

 
0.5

Expected volatility
 
28.6
%
 
24.1
%
 
32.3
%
Risk-free interest rate
 
0.1
%
 
0.1
%
 
0.1
%
Weighted average fair value per share
 
$
14.39

 
$
13.57

 
$
10.56

Schedule of Share-based Payment Award, Restricted Stock Units, Valuation Assumptions
The weighted average fair value for these performance units was determined using a Monte Carlo simulation model incorporating the following weighted average assumptions: 
 
Fiscal
 
2015
 
2014
 
2013
Risk-free interest rate
0.96
%
 
0.6
%
 
0.30
%
Volatility
28.7
%
 
36.9
%
 
37.9
%
Weighted average fair value
$
70.57

 
$
77.10

 
48.48

Schedule of stock-based compensation expense
The following table shows total stock-based compensation expense and related tax benefits included in the Consolidated Statements of Operations for fiscal 2015, 2014 and 2013 (in thousands):
 
Fiscal 2015
 
Fiscal 2014
 
Fiscal 2013
Cost of sales
$
2,530

 
$
2,393

 
$
2,151

Research and development
1,946

 
2,033

 
1,851

Selling, general and administrative
13,756

 
14,471

 
14,889

Income tax benefit
(4,247
)
 
(5,243
)
 
(5,292
)
 
$
13,985

 
$
13,654

 
$
13,599

Schedule of restricted stock award and restricted stock unit activity
The following table summarizes our time-based and performance restricted stock units activity for fiscal 2015, 2014 and 2013 (in thousands, except per share amounts):
 
Time Based Restricted Stock Units
 
Performance Restricted Stock Units
 
Number of
Shares
 
Weighted
Average
Grant Date
Fair Value
 
Number of
Shares
 
Weighted
Average
Grant Date
Fair Value
Nonvested stock at September 29, 2012
440

 
$
47.81

 
152

 
$
57.55

Granted
273

 
44.03

 
97

 
48.48

Vested (1)
(254
)
 
43.06

 
(28
)
 
49.50

Forfeited
(6
)
 
45.59

 
(8
)
 
53.30

Nonvested stock at September 28, 2013
453

 
$
48.22

 
213

 
$
54.63

Granted
226

 
65.80

 
52

 
77.10

Vested
(275
)
 
47.44

 
(33
)
 
43.25

Forfeited
(14
)
 
56.06

 
(3
)
 
46.99

Nonvested stock at September 27, 2014
390

 
$
58.66

 
229

 
$
61.46

Granted
237

 
64.84

 
51

 
70.57

Vested
(219
)
 
53.62

 
(38
)
 
53.46

Forfeited
(14
)
 
59.06

 
(43
)
 
53.46

Nonvested stock at October 3, 2015
394

 
$
65.17

 
199

 
$
67.09

__________________________________________
(1)
Service-based restricted stock vested during each fiscal year. Performance awards and units included at 100% of target goal; under the terms of the awards, the recipient may earn between 0% and 200% of the award.